Switzerland· 67371001
Luxturna 5 x 10e12, Konzentrat und Lösungsmittel zur Herstellung einer Injektionslösung
A voretigene neparvovec product containing voretigenum neparvovecum, registered in Switzerland by Novartis Pharma Schweiz AG and dispensed under Swissmedic category A, on the national reimbursement list. The same ATC class is registered in 13 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Voretigene neparvovec is registered in 13 of 19 countries.
Countries holding a registration under ATC S01XA27 (voretigene neparvovec), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 8 of them publish a price we can compare per daily dose
Voretigene neparvovec · ATC S01XA27
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
Swissmedic (Switzerland)- Active substance
- voretigenum neparvovecum
- Manufacturer
- Novartis Pharma Schweiz AG
- Country
- Switzerland (CH)
- ATC code
- S01XA27
- ATC class
- Voretigene neparvovec
- Swissmedic category
- A
- Reimbursed
- Yes
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin76806737100121 StkCHF 309773.95
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Voretigene neparvovec in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumLuxturna 5 10*12 vg/mlNovartis Europharm
- CanadaLUXTURNANOVARTIS PHARMACEUTICALS CANADA INC
- CzechiaLUXTURNANovartis Europharm Limited, Dublin
- SpainLUXTURNA 5 x 10¹² GENOMAS VECTORIALES/ML CONCENTRADO Y DISOLVENTE PARA SOLUCION INYECTABLENovartis Europharm Limited
- FinlandLuxturnaNovartis Europharm Limited
- FranceLUXTURNA 5 x 1 000 000 000 000 génomes de vecteur/mL, solution à diluer et solvant pour solution injectableNOVARTIS EUROPHARM (IRLANDE)
- United KingdomLuxturna 5 tera vector genomes/1ml concentrate and solvent for solution for injection vialsNovartis Pharmaceuticals UK Ltd
- IrelandLuxturna 5 × 1012 vector genomes/mL concentrate and solvent for solution for injectionNovartis Ireland Limited
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Luxturna
- Liechtenstein · Luxturna
- Norway · Luxturna
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/14007c54-c295-4554-a663-4fc04baea9a1 GET /v1/drugs/14007c54-c295-4554-a663-4fc04baea9a1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "voretigenum neparvovecum 5000000 Mio U",
"valid_from": "2026-08-01",
"limitations": "[{\"description\":\"Nach Kostengutsprache des Krankenversicherers nach vorgängiger Konsultation des Vertrauensarztes zur Behandlung von erwachsenen und pädiatrischen Patienten mit Sehverlust aufgrund einer erblichen Netzhautdystrophie, die auf nachgewiesenen biallelischen RPE65-Mutationen beruht, und die über ausreichend lebensfähige Netzhautzellen (retinaler Bereich innerhalb des hinteren Pols von >100 Mikrometer Dicke) verfügen.<br>\\nKeine Vergütung für Kinder unter 3 Jahren. Die Vergütung von Luxturna erfolgt pro Patient und Auge nur einmalig. Die Applikation von Luxturna wird nur in einem zertifizierten Behandlungszentrum durchgeführt.<br>\\nDie Novartis Pharma Schweiz AG erstattet dem Krankenversicherer, bei dem die versicherte Person zum Zeitpunkt des Bezugs versichert war, auf dessen erste Aufforderung hin für jede bezogene Packung Luxturna einen festgelegten Anteil des Fabrikabgabepreises zurück. Sie gibt dem Krankenversicherer die Höhe der Rückerstattung bekannt. Die Mehrwertsteuer kann nicht zusätzlich zu diesem Anteil des Fabrikabgabepreises zurückgefordert werden. Die Aufforderung zur Rückerstattung soll ab dem Zeitpunkt der Verabreichung erfolgen.<br>\\n<br>\\n\",\"costApproval\":null,\"indication\":\"21179.01\",\"isNew\":true,\"limitationCode\":null,\"priceModel\":null,\"validFrom\":\"2026-07-01\",\"validTo\":\"2026-09-30\"}]",
"galenic_form": "Inj Konz c Solv",
"therapeutic_area": null,
"sl_inclusion_date": "2021-11-01",
"self_retention_pct": 10
}See everything about voretigene neparvovec.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.